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A RETROSPECTIVE ANALYSIS OF VISUAL OUTCOMES IN LASER VISION 
CORRECTION OF HYPEROPIC PATIENTS USING THE VISX STAR S4 IR® 
AND WAVELIGHT® EX500 EXCIMER LASER PLATFORMS 
MICHAEL ALLEN NITZ 
ABSTRACT 
Background: Laser vision correction (LVC) developed as a more permanent alternative to 
other forms of refractive error correction. In the last several decades, visual outcomes of 
corneal refractive surgeries like LVC have improved dramatically with the discovery of 
new technologies and techniques designed to make the patient experience more 
comfortable and worthwhile. LVC has been shown to safely and effectively treat refractive 
errors in myopic and hyperopic eyes, with gradually improving outcomes and safety 
measures. However, it is important to note whether specific excimer lasers impart the same 
level of safe, effective treatments for patients as technology advances. 
Objective: This study aims to identify whether any statistically significant difference exists 
in the visual and refractive outcomes of hyperopic laser vision correction using two 
excimer laser platforms, the VISX STAR S4 IR® and the WaveLight® EX500, and to 
determine whether either laser shows any statistically significant difference in the rate of 
repeat surgery within one year post-operatively. 
Methods: Using EMR data collected from December 2008 through December 2016, 
distance and near visual acuity outcomes for hyperopic eyes treated with LASIK, LASEK, 
or PRK were compared at one month and up to one year post-operatively. Distance eyes 
were compared separately from monovision (near-targeted) eyes for visual acuity; 
		 vii 
however, if manifest refraction post-operative data were available, they were used to 
identify whether any difference existed in the refractive outcomes in either category. The 
number of enhancements (repeat surgeries) was also tabulated. X2 Tests of Independence 
were used to determine statistical significance. 
Results: Visual acuity outcomes in distance eyes at one month post-operatively showed 
similar trends between the two lasers, with 54% of the 267 VISX- and 60% of the 119 
EX500-treated eyes presenting with UCVA of 20/20 or better. Eyes available for follow-
up within one year post-operatively kept with this trend; 98 (51%) VISX- and 58 (67%) 
EX500-treated, eyes had UCVA measured at 20/20 or better. For monovision (treated for 
reading vision) eyes, 29 (47%) eyes and 19 (54%) of VISX- and EX500-treated eyes, 
respectively, read J1+ by one month post-operatively. By one year, 16 (39%) and 3 (21%) 
of available eyes read J1+ after treatment with the VISX and EX500 respectively. The 
relative enhancement rate was 7.82% (28 eyes) on the VISX and 4.19% (7 eyes) on the EX 
500. 
Conclusion: Overall, visual outcomes of laser vision correction for hyperopic patients did 
not differ consistently between the two lasers. Only distance-treated eyes measured up to 
one year post-operatively showed a statistically significant difference between the two 
lasers. The visual and, more importantly, the refractive outcomes were statistically similar 
at both one month and up to one year post-operatively irrespective of treatment type. 
Enhancement rate between the two lasers also showed no differences. Both lasers are 
similarly safe and effective for treating hyperopia and hyperopic astigmatism. 
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INTRODUCTION  
 
The human eye is an immensely powerful, complex organ, and diseases and 
dysfunctions of this structure can affect even the most basic aspects of life. Perhaps the 
most widely experienced disorders of the eye are refractive errors. The visual disturbances 
induced by these errors often require corrective lenses to allow the person to function 
normally during day-to-day activities. As such, the demand for a more permanent, 
affordable, and safe alternative to these lenses and their daily annoyances developed 
throughout the late 1900’s and early 2000’s in the form of refractive corneal surgery 
(Reinstein, Archer, & Gobbe, 2012). 
The Anatomy of Vision 
 A knowledge of the anatomy of the eye is vital to understanding vision. From 
anterior to posterior, the major structures of the eye involved in transmitting and 
interpreting received light include the cornea, aqueous humor, lens, vitreous humor, and 
retina. Vision is the byproduct of neurological processing of reflected light entering the 
eye, passing through the first four components, and contacting photoreceptor cells at the 
back of the eye. The light energy received by these cells is converted into electrical energy, 
which is transmitted through the optic nerve to the brain (“How Your Eyes Work,” 2017).  
 This passage of light occurs primarily due to the natural refractive properties of 
ocular structures. Each of the major anterior components possesses its own refractive 
index, which relates to the extent to which light is bent or refracted when passing from one 
component to another. Light waves pass first through the cornea and refract such that they 
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pass through aqueous humor toward the pupil and lens. Further refraction by the lens assists 
in focusing the received light waves, ideally onto the retina. A deficiency in any of these 
components – though primarily the cornea, lens, or retina – may result in difficulties 
processing light information correctly, thus leading to blurry vision, incomplete images, or 
even permanent loss of vision (Ohno-Matsui, 2016; Saw, 2006).  
Refractive Errors 
A healthy eye, where light passes through the anterior refractive components and 
focuses properly onto retinal photoreceptors at the back of the eye, is referred to as an 
emmetropic eye. However, refractive errors can occur such that light entering the eye does 
not focus on the retina due to some deficiency in part of the ocular organ. The most 
common refractive errors are myopia (nearsightedness), hyperopia (farsightedness) and 
astigmatism. Astigmatism itself may compound with myopia or hyperopia, further 
disrupting visual acuity. These errors may develop from a specific defect in one of the 
components involved in the passage of light into the eye, like the opacification of the lens 
during cataract formation leading to myopic refractive errors (Brown, 1993). Although, 
more commonly, errors result as part of the anatomical development of the eye during 
childhood and early adulthood (Flitcroft, 2014). 
In myopia, light rays entering the eye are refracted such that light is focused in the 
front of the retina. Unfortunately, this limits the ability of a myopic eye to see objects at a 
distance; however, objects closer to the eye appear more appropriately. This failure to focus 
light on the retina typically results from an increased axial length – anterior to posterior 
length of the eye itself – shifting the focus point forward.  It may also result from a 
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steepening of corneal tissue during eye development (Flitcroft, 2014; Richdale, Bullimore, 
Sinnott, & Zadnik, 2016). Traditional treatment for myopia involves the usage of diverging 
lenses designed to refract light more appropriately for the converging cornea prior to it 
encountering other intraocular structures. Corrective lenses prescribed for this purpose are 
written with a negative spherical power in diopters; the magnitude of this number indicates 
the power of the lens.  For higher spherical power myopes, contact lenses may better serve 
this purpose than traditional glasses (Stein, Stein, & Freeman, 2013). 
Conversely, refractive errors can produce an image that focuses behind the retina, 
which is the case for hyperopic eyes. Thus, unlike in myopic eyes, images further away 
from the eye itself (> 20 ft.) produce light waves that may properly focus on the retina, 
while closer objects may be more difficult to see for these patients. Like myopia, the 
primary causes of hyperopia lie in the axial length and anterior corneal curvature. A 
shortening of the axial length of the eye (axial hyperopia) or a flattening of the anterior 
corneal curvature (curvature hyperopia) each induce hyperopic refractive errors (Stein et 
al., 2013). During ocular development, it has been suggested that early in life (birth through 
6 years old) eyes tend to begin with relatively hyperopic refractions and progress toward 
emmetropia through anatomical and physiological changes within the eye. Failure of 
physiological changes to reduce this hyperopia for any reason may result in a permanent 
refractive error in adulthood (Flitcroft, 2014). Fortunately, accommodation provides a 
means for patients to overcome mild to moderate hyperopia.  
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Figure 1. Artistic Representation of Refractive Errors. This figure depicts the various 
refractive errors treatable with laser vision correction. a) Myopia, wherein parallel light 
rays entering the eye focus in front of the retina. b) Hyperopia, parallel light rays focus 
behind the retina. c) Various astigmatism presentations where parallel light rays are 
focused at perpendicular angles to one another; astigmatism may present with hyperopia 
or myopia as well. (Adapted from Stein et al., 2013). 
 
Accommodation refers to the ciliary body’s ability to control the shape of the 
relatively malleable lens such that it can refocus light from objects closer than 20 feet onto 
the retina. In fact, working primarily on close-up tasks and objects has been suggested as 
one of the causes for progressive myopia, though support for this is limited (Sivak, 2012). 
In mild to moderate hyperopes, accommodation may sufficiently focus light such that both 
uncorrected distance and near visual acuities fall within functional norms; many patients 
who accommodate sufficiently do not think to see an eye doctor for any correction at all. 
The ability of the eye to accommodate to light reflected from nearer objects is most 
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powerful in childhood and declines with age; however, this does not typically result from 
a decrease in ciliary muscle tone (American Academy of Ophthalmology, 2016; Glasser & 
Campbell, 1998). This degradation often results in the need for corrective lenses to see 
close objects after the age of 40 years old even for previously uncorrected eyes in a 
condition known as presbyopia, which is discussed more in depth in the monovision 
section. For those patients who present with unaccommodated hyperopia, treatment 
typically involves prescribing a converging corrective lens, which is identified by a positive 
spherical power (Stein et al., 2013). 
Finally, refractive errors may arise due to astigmatism. In eyes with astigmatism, 
light reflected from objects is refracted within the eye and projected such that two refracted 
light rays meet perpendicular to one another as opposed to at any specific point as with 
myopia or hyperopia. Both the cornea and lens may contribute to astigmatism; however, 
the anterior curvature of the cornea contributes the bulk of astigmatic refractive errors 
(Read, Vincent, & Collins, 2014). Treatment for astigmatism may also involve corrective 
lenses written for cylindrical power; lens prescriptions for these corrections may be written 
in either plus (converging) or minus (diverging) powers. Ophthalmologists tend to write 
prescriptions for lenses in positive cylinder, while optometrists tend to write prescriptions 
for lenses in negative cylinder. However, due to the nature of corrective converging lenses, 
overcorrecting myopic patients becomes a greater possibility when using positive 
cylinders; thus, refractive surgery specialists tend to work in negative cylinders. Negative 
cylinders were used in the refraction performed in this study. 
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Laser Vision Correction 
 As an alternative to corrective lenses, laser vision correction serves to reduce 
patients’ need for glasses and other corrective interventions by inducing permanent 
changes to the anterior corneal stroma and altering the focal point of light refraction within 
the eye (Bower, Weichel, & Kim, 2001). A variety of techniques have been employed over 
the past fifty years to make changes to the cornea, including early radial keratectomy 
treatments in the 1970s; however, development of excimer and femtosecond laser 
technology alongside LASIK, LASEK, and PRK techniques have improved visual 
outcomes dramatically (Reinstein et al., 2012).  
To determine a patients’ candidacy for the procedure, several measurements are 
taken prior to the initial meeting with the surgeon.  The details of how these measurements 
are conducted and what the results of these measurements entail for a patient’s procedure 
are discussed more fully in the methods section. The power of laser vision correction stems 
from the cornea providing the majority of the refractive power to the eye (Mahendiran, 
Elie, Nebel, Ryan, & Pierscionek, 2014). It is important to note the limitations of laser 
vision correction and the contraindications for LVC, however. Anatomically, the cornea 
consists of the surface epithelium, Bowman’s membrane, corneal stroma, Descemet’s 
membrane, and corneal endothelium (Mescher, 2013). Given that the procedure is 
performed on the cornea, any malformations and dystrophies of these corneal components 
or other conditions that might affect long-term ocular health may disqualify patients from 
the procedure. These include keratoconus, Fuchs corneal dystrophy, thin central corneal 
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pachymetry, autoimmune disease, immunodeficiency, and other long-term ocular disorders 
like glaucoma  (Bower et al., 2001).  
 This study focuses on three more modern, widely accepted treatment options for 
qualifying patients: LASIK, LASEK, and PRK (Duffey & Leaming, 2005). LASIK or 
Laser-Assisted In Situ Keratomeileusis involves the generation of a flap in the anterior 
cornea, allowing the surgeon to expose the corneal stroma for treatment by excimer laser 
with minimal damage to Bowman’s membrane and the corneal epithelium. The creation of 
the flap may be performed using either a microkeratome, which is a small, circular device 
applied with significant pressure, or, more recently, a femtosecond laser. The development 
of the femtosecond laser has allowed for the rapid generation of the flap, saving time and 
potentially reducing post-operative dryness and visual disturbances (Xia, Yu, Chai, Wang, 
& Li, 2015). The femtosecond laser and its functionality are discussed in the section on 
laser platforms. Most importantly, LASIK has proven effective in correcting refractive 
errors in both myopia and hyperopia and their respective astigmatisms (Alió, El Aswad, 
Vega-Estrada, & Javaloy, 2013; Balazsi, Mullie, Lasswell, Lee, & Duh, 2001; Varley et 
al., 2004).  
 Laser-Assisted Sub-Epithelial Keratectomy or LASEK involves a flap creation 
similar to LASIK; however, the flap is much thinner and is not generated by a femtosecond 
laser. Instead, a 20% alcohol solution is instilled into a ringwell for 40 seconds to loosen 
only the surface epithelium, after which the loosened epithelium can be lifted as a flap. 
This flap is very thin, approximately 50 micrometers thick, making it particularly friable; 
thus, for some LASEK procedures, the surface epithelium is completely removed, making 
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it effectively a photorefractive keratectomy (PRK) procedure. PRK is similar in technique 
(described in methods) to the LASEK procedure, with the exception being that the surface 
epithelium is completely removed and must regenerate more completely before visual 
stabilization. Both procedures have proven effective and safe in treating both myopic, 
hyperopic, and astigmatic refractive errors (Autrata & Rehurek, 2003; Habibollahi et al., 
2015; Hashemi, Aghazadeh Amiri, Tabatabaee, & Ayatollahi, 2016; O’Brart, Patsoura, 
Jaycock, Rajan, & Marshall, 2005; Shah et al., 2012). Given their similarities, for the 
purposes of this study, both procedures will be referred to as advanced surface ablation 
(ASA) for the remainder of this thesis. Additionally, particular attention will be paid to 
hyperopic treatments and outcomes; while no randomized comparisons have been made 
between treatment options (LASIK or ASA), non-randomized studies have shown equal 
efficacy between these options for treating hyperopic refractive errors (Settas, Settas, 
Minos, & Yeung, 2012). 
Monovision 	 As was mentioned previously, the accommodative ability of intraocular muscles 
declines with age, resulting in difficulties clearly seeing nearby objects and text after 40 
years of age. This condition is called presbyopia (American Academy of Ophthalmology, 
2016). Fortunately, by treating separate eyes for reading and distance vision (i.e. 
monovision), it is possible to minimize patients’ need for reading and distance glasses 
(Charman, 2014; Mantry & Shah, 2004). In terms of laser vision correction, 
undercorrecting myopia (i.e. leaving one eye nearsighted) or overcorrecting hyperopia 
(creating nearsightedness) both impart the effects of monovision.	  
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Laser Platforms 
 Femtosecond laser technology allows for safe LASIK flap generation using 
lamellar, short wavelength beams to create micro air pockets within the corneal tissue 
(Kohnen, Schwarz, Remy, & Shajari, 2016); these micro air pockets create consistent, 
efficient flaps reducing intraoperative time and post-operative complications as compared 
to mechanical microkeratomes (J.-H. Kim, Lee, & Rhee, 2008; Knorz & Vossmerbaeumer, 
2008; Kohnen et al., 2016; Xia et al., 2015). The IntraLase® iFS 60-kHz laser (Abbott 
Medical Optics) used in this study is comparable to the Alcon WaveLight® FS200 (Alcon 
equivalent fifth generation femtosecond laser) in producing quality, reproducible flaps for 
predictable, safe LASIK outcomes (Liu et al., 2016). 
In addition to the femtosecond flap-generation laser, the excimer laser induces the 
permanent corneal changes that aim to improve uncorrected visual acuities. For treating 
myopia, excimer laser ablation flattens the relatively steep cornea, while for. Thus, 
confirming that individual, commercially available excimer lasers produce effective, safe, 
reproducible results in terms of those visual outcomes is important when applying these 
treatments to patients’ eyes. This study focuses on the comparability of two excimer lasers 
– the Abbott VISX STAR S4 IR® (Abbott Medical Optics, Inc.) and the Alcon WaveLight® 
EX500 (Alcon Laboratories, Inc.) lasers.  The inherent differences between the two lasers 
lies not only in their manufacturers but also in their functionality. 
The VISX laser boasts a variable spot scanning (VSS) treatment profile; this means 
that each beam emitted by the laser for treatment may vary in size (0.65 to 6.5mm) and rate 
of fire (variable repetition rate, VRR), providing a controlled ablation zone up to 8mm in 
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diameter (“STAR S4 IR® Excimer Laser | Abbott Vision,” n.d.). The CustomVue® option 
for treatment with this platform combines this VSS and VRR with images from their 
WaveScan scanners to target higher order aberrations (HOA’s). Higher order aberrations 
are measured by the WaveScan, which shines light into the eye and measures how that light 
is refracted and reflected back to the system, creating a customized treatment profile for 
individual eyes. Using this wavefront-guided approach, post-operative higher order 
aberrations may be reduced as compared to other methods of treatment (Padmanabhan, 
Mrochen, Basuthkar, Viswanathan, & Joseph, 2008). However, this study focuses 
primarily on the standard (“traditional”) treatment functionality of the laser, rather than the 
CustomVue® option. The VISX platform has proven effective in treating both myopia, 
hyperopia, and astigmatism irrespective of treatment type (LASIK and surface ablation) in 
previous studies (Jackson, Tuan, & Mintsioulis, 2011; Kulkarni et al., 2013; Schallhorn et 
al., 2016).  
 The EX500 laser shines due to the speed at which it provides treatment. Operating 
at 500 Hz, this laser is able to treat refractive errors significantly faster than its VISX 
counterpart, which Alcon suggests may decrease the risk of corneal dehydration and 
fixation losses intraoperatively thereby improving visual outcomes (“Wavelight® Ex500 
Excimer Laser | myalcon.com,” n.d.). This laser evolved from its 400 Hz counterpart, the 
Allegretto WaveLight® Eye-Q laser, which has positive, effective outcomes when treating 
myopia, hyperopia and astigmatism using LASIK and ASA treatment procedures (Costa et 
al., 2014; George, Shah, Hood, & Krueger, 2010; Kezirian, Moore, Stonecipher, & 
SurgiVision Consultants Inc WaveLight Investigator Group, 2008; Ziaei, Mearza, & 
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Allamby, 2015).  Comparison studies conducted between the 400-Hz laser and the newer 
500-Hz laser indicate better centration and eye-tracking capabilities (and therefore better 
visual outcomes) on the newer laser (J. Kanellopoulos & Asimellis, 2015). Although no 
ASA-specific studies could be identified using only the EX500 laser, it has been shown to 
produce appropriate results for LASIK treatments (A. J. Kanellopoulos & Asimellis, 2013; 
J. Kanellopoulos & Asimellis, 2013). 
Fewer studies have been performed on the individual treatment outcomes of the 
EX500 laser; however, several comparison studies have been conducted between the VISX 
STAR S4 IR® and both the Allegretto and EX500 lasers. For myopic treatments, no 
significant difference has been identified between the visual, refractive, and safety 
outcomes between either the VISX or Allegretto lasers,  though the evidence of how 
wavefront-guided (VISX CustomVue®) versus wavefront-optimized (modern Alcon 
lasers) treat HOA’s is inconclusive (He & Manche, 2015; Khalifa, Mossallam, Massoud, 
& Shaheen, 2015; Kung & Manche, 2016; Moshirfar et al., 2011; Padmanabhan et al., 
2008). Also, no identifiable difference between either the EX500 or VISX lasers could be 
identified from literature review of myopic treatments (Meidani & Tzavara, 2016); 
however, one presentation noted fewer post-operative spherical aberrations on the EX500 
laser (S. I. Kim et al., 2014).  
Despite the extensive research into myopic LVC, limited comparisons have been 
made for hyperopic treatments on these lasers.  One study analyzing outcomes for 
hyperopic treatments between the VISX and Allegretto lasers showed no statistically 
significant difference between the CustomVue® and wavefront-optimized (Allegretto) 
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groups (Sáles & Manche, 2014). However, to the best of our knowledge, no study 
comparing the efficacy and safety of the WaveLight® EX500 to the standard option on the 
VISX STAR S4  IR® in treating hyperopic eyes has been published. This thesis aims to 
approach that topic and provide evidence in line with previous studies that no significant 
difference exists in the visual or refractive outcomes of either laser in treating hyperopes. 	 	
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SPECIFIC AIMS 
 
 
Laser vision correction technology has advanced considerably in the past several 
decades. With these advancements, several studies have been completed comparing the 
visual outcomes of LVC using a variety of excimer lasers, including the VISX 
CustomVue® STAR S4 IR® and Alcon WaveLight® EX500 excimer lasers. These studies 
have compared treatment outcomes for myopic patients separately on each laser and 
comparatively between the two lasers. The VISX CustomVue® treatments and the Alcon 
WaveLight® treatments have each been proven effective and safe for treating hyperopia 
separately, and the CustomVue® treatments have been compared to the Allegretto Eye-Q 
excimer laser.  However, no study has been conducted comparing the visual outcomes of 
the traditional function of the VISX to the EX500 for hyperopic treatments. 
This study aims to accomplish just that.  Hyperopic eyes treated either with the 
traditional function of the VISX STAR S4 IR® or the WaveLight® EX500 excimer laser 
were compared to identify any statistically significant differences in the visual outcomes, 
refractive outcomes, and enhancement rates between each laser to verify that safe and 
effective treatments may be carried out on either laser. 
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 METHODS 
 
Laser Vision Correction Consultation 
  Patients evaluated for laser vision correction underwent Boston Laser’s standard 
examination prior to scheduling treatment. Additionally, the surgical techniques and post-
operative care described herein were conducted as standard practices performed at Boston 
Laser. The preliminary examination included checking corrected and uncorrected near and 
distance visual acuities, manifest refraction, keratometry, pachymetry, corneal topography, 
Zone-Quick dry eye test, and pupilometry. Patients were then dilated to perform a 
cycloplegic refraction and a retinal health exam. All distance visual acuities both for the 
preliminary examination and post-operative examinations were tested using a Snellen chart 
projection calibrated for a distance of twenty feet; near visual acuities were tested at 
fourteen inches using a Rosenbaum Pocket Vision Screener card and recorded on the Jaeger 
scale. Keratometry values were measured using an autorefractor. Corneal topography was 
conducted using either the Oculus Pentacam (Oculus, Inc.) or Galilei G4 (Zeimer 
Ophthalmic Systems) topography platforms, which also provided central, thinnest corneal 
pachymetry values. In order to rule out keratoconus and other corneal dystrophies, special 
attention is paid to the inferior-superior ratio of cornea thickness (I-S ratio). An I-S ratio 
greater than 1.5 indicates an increased risk for a condition known as keratoconus or post-
operative ectasia; thus, LASIK, which affects more of the corneal stroma due to flap 
creation, is contraindicated typically in these patients. A Colvard pupilometer was used to 
assess mesopic pupil size, which was used to determine the appropriate optical zone for 
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use during the procedure. Using this information, the surgeon then determined the 
treatment appropriate for the patient between LASIK, LASEK, and PRK (Figure 2). 
 
Figure 2. Boston Laser Hyperopic Refractive Surgery Algorithm. This figure 
illustrates the Boston Eye Group’s basic decision-making process for identifying 
potential candidates for hyperopic LVC. These treatment parameters are evaluated with 
the limitations of the excimer lasers and FDA-approved treatment options in mind. 
 
Pre-Operative Meeting 
 On the day of surgery, patients confirmed their understanding of the benefits, 
alternatives, and risks of their laser vision correction. Manifest refractions were repeated if 
the patient had previously not been out of contact lenses for at least one week prior to their 
initial evaluation, if significant (>0.5D) discrepancies between previous cycloplegic and 
manifest refractions, or if their most recent manifest refraction was conducted greater than 
three months prior to their surgery date. Corneal topographies were repeated for patients 
Hyperopia
MRx ≤	5.00
Post-Operative	K	<	50
Pachy >	500
I-S	>	1.50
ASA
I-S	<	1.5
LASIK
Pachy 450	-500
ASA
Pachy <	450
Clear	Lens	Extraction
Post-Operative	K	>	50
Clear	Lens	Extraction
MRx >	5.00
Clear	Lens	Extraction
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whose most recent topography was taken more than twelve months prior to their day of 
surgery. Patients met with their respective surgeon for any final questions before being 
advised of the post-operative restrictions and medication instructions. A pre-operative drop 
of nepafenac 0.3% ophthalmic suspension and ciprofloxacin hydrochloride 0.3% was 
instilled into each operative eye prior to treatment. Additionally, patients were offered 5mg 
of diazepam (Valium) prior to treatment to reduce any possible anxieties associated with 
the procedure. 
Surgical Technique 
 Irrespective of treatment type, each patient was prepared in the operating room 
initially with a topical betadine scrub over each operative eye. Additionally, one drop of 
topical anesthetic 1% proparacaine hydrochloride was instilled into each operative eye 
prior to beginning surgery. Each operative eye underwent LASIK, LASEK, or PRK 
procedures as described below. The excimer laser treatment itself depended on which 
excimer laser was used for the treatment, either the VISX STAR S4 IR® traditional 
treatment or WaveLight® EX500 wavefront-optimized treatment. Upon completion of the 
treatment, two drops of a 1:1 1% prednisolone acetate-0.3% ciprofloxacin cocktail were 
instilled in the affected eye(s). 
LASIK 
  Following aseptic preparation, LASIK flap generation took place using the 
IntraLase Femtosecond Laser. Ideal flap thicknesses were verified in the laser system prior 
to treatment, with a target depth of between 100 and 110 microns. Suction was applied 
using the appropriate patient interface prior to docking the laser with attached optical cone. 
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A pupil-centered position was verified by the surgeon using minor adjustments as 
appropriate before instructing the patient to remain still while the laser generated the flap. 
After completion of the flap cut, the docking cone and suction interface were removed from 
the eye and discarded; the patient bed was then mechanically rotated to the excimer laser 
(either the VISX STAR S4 IR® or WaveLight® EX500). A tegaderm transparent film 
dressing was applied to the patient’s superior eyelid to clear the surgical field of eyelashes. 
A speculum was used to hold the patient’s eyes open for the duration of the treatment 
procedure. A corneal marking pen was then used to mark the boundary between the flap 
and remaining corneal surface for appropriate repositioning after excimer treatment. Pre-
operative pachymetry values were verified using a portable pachymeter or laser system 
pachymetry functions and compared to the patient’s Pentacam or Galilei G4 pachymetry 
values prior to proceeding with treatment. The flap was then lifted using a LASIK Flap 
Lifter; a flap-lifted pachymetry value was then measured to verify a safe, calculated flap 
thickness and remaining corneal stroma thickness prior to excimer laser treatment. After 
the completion of the laser treatment, the corneal flap was repositioned using an irrigating 
cannula and balanced saline solution (BSS).   
LASEK and PRK 
  During both the LASEK and PRK preparations, a tegaderm transparent film 
was used to clear eyelashes from the surgical field prior to the application of a speculum 
to keep the patient’s eye open. Topical 1% proparacaine hydrochloride was reapplied as 
anesthetic. An 8mm ring well was then placed firmly over the treatment area, and a 20% 
dehydrated alcohol solution instilled into this well for forty seconds. The treated corneal 
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epithelium was then rinsed thoroughly with 5mL of 0.9% saline solution (Addipak). For 
LASEK treated eyes, the loosened epithelium was lifted as a flap prior to excimer laser 
treatment. For PRK treated eyes, this epithelium was removed completely prior to excimer 
laser treatment using a dry Weck-Cel®. Upon completion of excimer treatment, a sponge 
soaked mitomycin-C (MMC) was applied to the exposed cornea to reduced corneal 
scarring during the healing process. The MMC was allowed to soak the cornea for a period 
of time dependent upon the treatment ablation (Habibollahi et al., 2015; Teus, de Benito-
Llopis, & Alió, 2009) (Table 2). Upon completion of MMC soak, 10 mL of cold 0.9% 
saline solution was used to rinse and hydrate the cornea. Afterward, a bandage contact lens 
and 1 drop of 1% cyclogyl were placed in the eye to reduce patient discomfort during the 
healing process.  
Post-Operative Care and Instructions 
 Printed post-operative instructions were provided to patients, which included no 
squinting, squeezing, or rubbing operative eye(s) during the healing process (at least two 
weeks). Additionally, patients were instructed to refrain from swimming, saunas, hot tubs, 
contact sports, and heavy exercise during first few weeks post-operatively. Patients were 
instructed to sleep with provided clear, plastic eye shields over each operative eye for one 
week following their procedure. After returning home from the procedure, patients were 
instructed to rest with eyes closed for four hours after the procedure before starting post-
operative drops. All patients were seen in the clinic for 1 day, 1 week, and 1 month post-
operative appointments.  
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Patients having undergone LASIK waited with their eyes closed in the clinic for 
thirty minutes before having their flap position checked by the surgeon. After this 
verification, a clear plastic eye shield was taped over the treated eye(s), and the patients 
were instructed to keep these shields in place for the remainder of the day of their surgery 
in addition to the standard instructions to wear them while sleeping. LASIK patients are 
instructed to use one drop of 1% prednisolone acetate ophthalmic solution into each 
surgical eye hourly while awake beginning four hours after the procedure for post-
operative days 1-3 (including the day of surgery). On post-operative days 4 and 5, patients 
were instructed to decrease their usage of these drops to four times daily while awake. 
Patients were also told to instill an antibiotic drop four times per day while awake into each 
operative eye on days 1-5 post-operatively. Patients were instructed to discontinue both the 
prednisolone and antibiotic drops starting on day 6. 
Patients receiving LASEK and PRK treatments were prescribed 1% prednisolone 
acetate eye drops. The steroid regimen for these patients involved using the drops four 
times per day into each operative eye during the first week post-operatively, three times 
per day during the second week, twice per day during the third week, and once per day 
during the fourth week. Patients were instructed to discontinue the prednisolone drops after 
the fourth week. Additionally, these patients were instructed to use an antibiotic eye drop 
in each operative eye four times per day until the bandage contact lens was removed by a 
physician, typically at the patient’s one week post-operative appointment. As optional 
medications for managing patient discomfort post-operatively, a prescription for Nevanac 
(nepafenac 0.1%) to instill twice daily into operative eye(s) and 15 tablets of 
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acetaminophen/codeine (300-30mg) to take once (1 tablet) every 6 hours with food were 
provided. Patients were also asked to take 1000mg of Vitamin C daily for three months 
post-operatively to facilitate appropriate healing of surface epithelium. 
Inclusion and Exclusion Criteria 
 A report was generated collecting EMR data for eyes treated with laser vision 
correction (either LASIK, LASEK, or PRK) between December 2008 and December 2016 
whose manifest refractive spherical power was greater than 0.00. Eyes with a refractive 
spherical equivalent less than 0.00 were excluded from this analysis; however, eyes with 
mixed astigmatism were included and discussed. Refractive spherical equivalent was 
identified by adding the full power of the spherical refraction to half the power of the 
cylinder refraction. Eyes were included irrespective of treatment type – either LASIK, 
LASEK, or PRK. Particular attention was paid to LASIK treated eyes as significantly more 
treatments fell into that category. Due	to	this	discrepancy	between	the	number	of	eyes	treated	with	LASIK	and	the	number	of	eyes	treated	with	LASEK	and	PRK,	LASEK	and	PRK	 were	 collectively	 analyzed	 as	 advanced	 surface	 ablation	 (ASA).	 Only eyes 
available as part of a patient’s electronic medical record were included in the study. Patients 
whose surgery was performed at the Boston Eye Group but whose post-operative care was 
provided by a co-managing physician were not included as their follow-up data was not 
available for analysis. Patients unavailable for follow-up through up to one year post-
operatively were included if data existed for at least one month post-operatively; however, 
patients who did not have at least 1 month of follow-up data were excluded entirely. The 
total number of eyes treated using the VISX STAR S4 IR®	excimer	laser	was	358	(267	
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distance,	 91	 monovision),	 and	 the	 total	 number	 of	 eyes	 treated	 using	 the	 Alcon	WaveLight®	 EX500	 eximer	 laser	was	 167	 (119	 distance,	 48	monovision).	 A	more	detailed	depiction	of	included	eyes	separated	by	treatment	type	and	target	correction	can	be	found	in	Table	1.		
Table 1. Number of Eyes Treated with LASIK, LASEK, and PRK on Each Excimer 
Laser. The total number of eyes treated using each excimer laser identified by treatment 
type and refractive aim. Near vision aims were determined based on age and patient 
preference for monovision. 
EXCIMER	LASER	 TARGET	 TREATMENT	TYPE	 NUMBER	OF	EYES	
VISX	STAR	S4	IR®	 Distance	
LASIK	 238	LASEK	 23	PRK	 6	
Near	 LASIK	 76	LASEK	 10	PRK	 5	
Alcon	WaveLight® 
EX500	
Distance	 LASIK	 93	LASEK	 18	PRK	 8	
Near	 LASIK	 36	LASEK	 10	PRK	 2	
 
Data Collection and Grouping 	 Patient	 eyes	were	 initially	 grouped	 according	 to	 treatment	 aim	 -	 either	 for	distance	 or	monovision	 -	 and	 additionally	 separated	 according	 to	 treatment	 type,	LASIK,	 LASEK,	 or	 PRK.	 At	 the	 patient’s	 standard	 one	 month	 post-operative	
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appointment,	visual	acuities	were	recorded	and	these	visual	acuity	measures	were	used	to	analyze	visual	outcomes.	For	monovision	eyes	whose	near	visual	acuity	was	not	measured,	no	statistical	or	otherwise	comparison	was	drawn	between	near	visual	acuities	and	distance	visual	acuities;	however,	monovision	eyes	with	post-operative	manifest	refractions	were	included	in	refractive	analyses	with	respect	to	their	target	refraction.	If	the	patients	returned	to	the	clinic	for	follow-up	within	one	year	post-operatively,	 their	 latest	 visual	 acuity	 measurements	 were	 analyzed	 for	 long-term	stability	and	efficacy	of	each	excimer	laser’s	treatment.		 Patient’s	whose	visual	outcomes	achieved	target	visual	acuity,	the	refractive	outcome	 was	 identified	 as	 that	 patient’s	 target.	 For	 example,	 distance	 eyes	 were	targeted	 for	 a	 plano	 spherical	 equivalent	 (0.00	 RSE);	 eyes	 measuring	 20/20	uncorrected	 were	 considered	 plano	 post-operatively.	 For	 a	 number	 of	 patients,	manifest	 refractions	 were	 performed	 on	 eyes	 whose	 visual	 acuity	 was	 less	 than	expected	(either	 less	than	20/20	for	distance	eyes	or	 less	than	J1+	for	monovision	eyes).	 These	manifest	 refractions	were	 used	 to	 determine	 the	 refractive	 spherical	equivalent	post-operatively,	and	that	RSE	was	used	to	determine	the	distance	from	the	target	refractive	power.	These	distances	were	separated	by	those	within	0.5	D	of	the	target,	1.0	D	of	the	target,	and	>	1.0	D	of	the	target.	If	a	patient	required	or	requested	an	enhancement,	their	visual	acuity	prior	to	the	enhancement	was	used	as	their	latest	visual	acuity	up	to	one	year.	The	number	of	eyes	enhanced	was	recorded	both	for	distance	and	near	vision	eyes.	Enhancement	eyes	were	excluded	from	statistical	analysis	if	the	enhancement	was	performed	due	
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to	patient	dissatisfaction	with	monovision,	distance	vision	(when	they	later	wanted	monovision),	or	if	the	initial	refractive	target	was	achieved.	
Statistical Analysis 
 The statistical tools used were X2 Tests of Independence to determine whether any 
significant difference existed between the excimer lasers in any of the measured values. 
The independent categorical variable was treatment laser, and the dependent categorical 
variable was visual acuity or post-operative refractive group. In order to impart the most 
power to the statistical calculations, treated eyes were grouped according to optimal, 
adequate, and suboptimal outcomes. For example, eyes whose UDVA was 20/20 or better 
by their post-operative visit were compared to eyes whose UDVA was between 20/25 and 
20/40 and to eyes whose UDVA was worse than 20/40. This method reduced the likelihood 
of not identifying a statistically significant difference between the outcomes on either laser 
or of having too few eyes in any individual category. Table 2 depicts the possible categories 
into which treated eyes could have been included; however, not every visual level 
contained any treated eyes. For refractive outcomes, chi square analyses were conducted 
using eyes within 0.5 D, 1.00 D, or greater than 1.00 D of the target refractive outcome for 
both the one month and one year groups. 
 
Table 2. Possible Categories for Distance and Near Visual Acuities. The distance visual 
acuity possibilities measured at 20 feet from the projected Snellen chart and the near visual 
acuity possibilities measured at 14 inches from the patient using the Jaeger scale, written 
adjacent to their DVA equivalents. 
Distance Visual Acuity Near Visual Acuity 
20/15 - 
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20/20 J1+ 
20/25 J1 
20/30 J2 
20/40 J3 
20/50 J4 
20/60 J5 
20/70 J7 
20/80 - 
20/90 - 
20/100 J10 
20/150 - 
20/200 J16 
20/400 - 	 	
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RESULTS 
 
Distance Vision Correction 
  For eyes targeted for distance vision, or plano spherical power (0.00 RSE), 267 
included eyes were treated using the traditional setting on the VISX STAR S4 IR®, and 
119 included eyes were treated using the Alcon WaveLight® EX500 excimer lasers. These 
all had distance visual acuity measurements for at least one month post-operatively. When 
all treatment types were compared, the UDVA’s for both lasers exhibited primarily one 
month post-operative visual acuities around 20/20 (Figure 3a). More specifically, 54% of 
eyes treated on the VISX and 60% of eyes treated with the Alcon laser showed an 
uncorrected visual acuity of 20/20 or better at one month post-operatively (Figure 3b) 
(C2(2, N = 386) = 1.299, p = 0.5223). This trend held for the LASIK group, which was 
comprised of 238 VISX eyes and 93 Alcon eyes. On the VISX, 55% of LASIK eyes treated 
for distance vision achieved an uncorrected distance visual acuity of 20/20 or better; on the 
Alcon laser, 63% of LASIK eyes treated for distance vision achieved the same uncorrected 
visual acuity (Figure 3c) (C2(2, N = 331) = 1.187, p = 0.5525). For eyes treated with ASA, 
the one month post-operative trend was less clear. Using the VISX laser, 29 eyes were 
identified as having undergone ASA, and 26 eyes were treated using the EX500. Neither 
laser produced uncorrected visual acuity measures better than 20/20 by one month; the 
VISX produced 17% while 46% of Alcon eyes were 20/20 by one month post-operatively 
(C2(2, N = 55) = 5.401, p = 0.0672). No ASA-treated distance eyes showed an uncorrected 
DVA less than 20/50 in the VISX group or less than 20/60 in the Alcon group (Figure 3d). 
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Figure 3. Uncorrected Distance Visual Acuities at One Month Post-Operatively. The 
total number of eyes and relative frequency of UDVA outcome plotted for each treatment 
type. Solid bars show VISX treated eyes; hollow bars show Alcon treated eyes. a) The total 
number of treated eyes on each excimer laser. b) The relative frequency of UDVA 
outcomes for all treated eyes. c) The relative frequency of UDVA outcomes for LASIK 
treated eyes. d) The relative frequency of UDVA outcomes for ASA treated eyes. 
 
Fewer eyes had distance visual acuity measurements available up to one year either 
because their next visit to the clinic was outside the time frame of one year or because they 
were lost to follow up. These eyes showed the same relative trend as the one month post-
operative eyes. Up to one year, 191 eyes were evaluated after treatment with the VISX 
laser, and 58 eyes were evaluated after treatment with the Alcon laser (Figure 4a). Overall, 
	27 
51% of VISX treated eyes and 68% of Alcon treated eyes showed an UDVA of 20/20 or 
better at their latest follow-up within their first year prior to surgery (C2(2, N = 249) = 
8.700 p = 0.0129) (Figure 4b). Of LASIK-treated eyes only, 170 eyes were treated using 
the VISX laser while only 46 eyes were treated using the Alcon laser; 51% of LASIK VISX 
eyes and 63% of LASIK Alcon eyes were 20/20 or better in this time frame (C2(2, N = 
216) = 5.053, p = 0.0799) (Figure 4c). Within one year, the number of ASA-treated eyes 
measured for UDVA was much lower, with 21 VISX and 12 Alcon eyes presented. Given 
the measurements on these few eyes, 52% of VISX treated eyes and 83% of Alcon treated 
eyes were 20/20 or better by their latest post-operative appointment up to one year (C2(2, 
N = 33) = 4.314, p = 0.1157) (Figure 4d). 
Near Vision Correction 
Included monovision eyes totaled 91 on the VISX laser and 48 on the Alcon laser. 
Of these eyes, only 62 VISX and 35 Alcon eyes had available, recorded near visual 
acuities at least one month post-operatively. With these measured values, the same 
general increasing trend toward J1+ outcomes was exhibited in both groups  at one month 
post-operatively (Figure 5a). Between the two groups at that time, 47% of VISX eyes and 
54% of Alcon eyes were measured to see J1+ (C2(2, N = 97) = 2.519, p = 0.2839) (Figure 
5b). When analyzing the one month post-operative results of LASIK-treated monovision 
eyes, 49% of VISX eyes and 59% of Alcon eyes were J1+ (C2(2, N = 82) = 2.034, p = 
0.3618) (Figure 5c). Similar to the distance eye groups, the ASA-treated eyes were far 
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Figure 4. Uncorrected Distance Visual Acuities at Up to One Year Post Operatively. 
The total number of eyes plotted in addition to the relative frequency of visual outcomes 
on each laser for each treatment type. The solid bars represent VISX eyes, and the hollow 
bars represent Alcon eyes. a) The total number of eyes with UDVA measurements 
available up to one year post-operatively. b) Relative frequencies of UDVA outcomes for 
all treated eyes. c) Relative frequencies of UDVA outcomes for LASIK treated eyes. d) 
Relative frequencies of UDVA outcomes for ASA treated eyes. 
 
fewer in number with 9 eyes treated on the VISX and 6 eyes treated on the Alcon laser 
included in this study. The relative frequency of J1+ ASA-treated eyes at one month post-
operatively was 33% on both the VISX and Alcon lasers (C2(2, N = 15) = 0.875, p = 
0.6456) (Figure 5d). 
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Figure 5. Uncorrected Near Visual Acuities for Monovision Eyes at One Month Post-
Operatively. A graphical representation of the total number of monovision eyes with 
measured near visual acuities at one month post-operatively. Solid bars represent VISX 
eyes, and hollow bars represent Alcon eyes. a) The total number of eyes with 
measurements. b) Relative frequency of all treatments’ visual outcomes. c) Relative 
frequency of LASIK-treated near vision outcomes. d) Relative frequency of ASA-treated 
near vision outcomes. 
For monovision patients who followed up within one year after their initial 
treatment, 56 total eyes were identified with their corresponding near visual acuity 
measurement (41 VISX, 15 Alcon) (Figure 6a). Overall frequency of eyes measuring at 
J1+ by that point was 39% and 21% on the VISX and Alcon lasers respectively (X2(2, N = 
55) = 3.643, p = 0.1618) (Figure 6b). For only LASIK-treated monovision eyes, 12 eyes 
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(37.5%) on the VISX and 2 eyes (20%) on the EX500 were recorded as J1+ by their latest 
appointment up to one year (X2(2, N = 42) = 2.562, p = 0.2778) (Figure 6c).  
 
Figure 6. Uncorrected Near Visual Acuities for Monovision Eyes at Up to One Year 
Post-Operatively. The total number of eyes and relative frequencies for monovision 
treated eyes on both the VISX (shaded) and EX500 (unshaded) excimer lasers. a) Graphical 
representation of total eyes available for UNVA measurement up to one year after their 
original procedure. b) Relative frequencies of UNVA measurements for all treatment types 
up to one year post-operatively. c) Relative frequencies of UNVA measurements for 
LASIK-treated eyes up to one year post-operatively. d) Relative frequencies of UNVA 
measurements for ASA-treated eyes up to one year post-operatively. 
 
Monovision eyes treated with ASA in the same time frame were again fewer in number 
with 9 eyes treated with the VISX and 4 with the EX500. In this small sample, 4 VISX 
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eyes (44%) and 1 Alcon eye (25%) were J1+ when measured (X2(2, N = 13) = 1.197, p = 
0.5497) (Figure 6d). 
Refractive Outcomes 
 At one month post-operatively, a total of 274 VISX eyes and 149 EX500 eyes had 
recorded manifest refractions or were measured at their target visual outcome (i.e. 20/20 
for distance eyes and J1+ for monovision eyes). The VISX-treated eyes presented with 250 
(91%) eyes within 1.00 D of target RSE and 212 (77%) eyes within 0.50 D of target RSE. 
Measured EX500 eyes presented with 134 (90%) eyes within 1.00 D of target RSE and 101 
(68%) eyes within 0.50 D of target RSE (X2(2, N = 423) = 1.396, p = 0.4975) (Figure 7a). 
 By their latest appointment up to one year after their treatment, 192 VISX eyes and 
69 Alcon eyes were refracted or were measured at their target visual outcome. Similar 
relative frequencies were found for each laser. The VISX was found with 178 (92%) eyes 
within 1.00 D of target RSE and 141 (73%) eyes within 0.50 D of target RSE. The EX500 
produced 64 (93%) eyes within 1.00 D of target RSE and 47 (68%) eyes within 0.50 D of 
target RSE (X2(2, N = 261) = 0.1997, p = 0.9050) (Figure 7b).  
Enhancement Rate 	 The recorded number of retreatments or enhancements on each laser was 40 and 10 
eyes on the VISX and EX500 lasers respectively.  The details of these enhancements are 
summarized in Table 3. An enhancement treatment was labeled as a touch up if it was 
aimed at improving the patient’s vision toward the previous refractive aim. 
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Figure 7. Refractive Outcomes for All Treated Eyes at One Month and Up to One 
Year Post-Operatively. The relative frequency of eyes falling either 0.5 D, 1.00 D, or 
more than 1.00 D away from the target RSE. a) Relative frequency of eyes with manifest 
refractions conducted at their one month post-operative appointment. b) Relative frequency 
of eyes with manifest refractions conducted at their latest appointment up to one year post-
operatively. 
 
Certain criteria resulted in the exclusion of retreated eyes from statistical calculations. 
These included reversal of monovision, enhancement for monovision (where distance 
vision was the original target), or achievement of initial refractive target. Ultimately, 12 
VISX eyes and 3 Alcon eyes were excluded from the enhancement calculations in order to 
limit the effects of confounding factors not related to the laser’s function. After these 
exclusions, the enhancement rate for the VISX was 8% (28 eyes) and the Alcon was 4% (7 
eyes) (X2(1, N = 35) = 2.41, p = 0.1205) (Table 3). 					
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Table 3. Enhancement Data. The total number of enhancements were recorded. Touch 
ups referred to improvements upon a previously planned treatment (i.e. improvement on a 
distance vision target after initial insufficient distance treatment). This also includes a set 
of exclusion criteria related to these enhancements, including enhancements conducted to 
reverse an initially chosen treatment and enhancements performed even though the initial 
target had been achieved. One eye targeted for intermediate vision improvement (i.e. 
computer reading) after distance vision correction was excluded from EX500-treated eyes. 
 
REASON FOR ENHANCEMENT VISX EX500 
Touch Up 33 8 
Correction for Distance (Initially MV) 3 0 
Correction for MV (Initially Distance) 4 1 
Other 0 1 
TOTAL ENHANCEMENTS 40 10 
      
REASON FOR EXCLUSION     
Enhancement >1 year from original procedure 4 0 
Enhancement after achieving initial target RSE 1 1 
Reversal of Initially Selected Treatment 7 2 
TOTAL EYES EXCLUDED 12 3 
      
TOTAL INCLUDED ENHANCEMENT EYES 28 7 
Relative Frequency of Enhancement (%) 7.82 4.19 	
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DISCUSSION 
 
 The primary goal of this study was to establish a statistically identical correlation 
in visual outcomes between the WaveLight® EX500 and VISX STAR S4 IR® excimer 
lasers for the treatment of hyperopic refractive errors and hyperopic astigmatism. To 
accomplish this, eyes treated for these refractive errors using the two lasers with at least 
one month and up to one year of post-operative visits were analyzed retrospectively for 
distance and near visual outcomes, refractive outcomes, and the number of enhancements 
(or repeat surgeries) on each laser. Eyes corrected for distance and eyes corrected for 
reading vision were evaluated separately and shall be discussed separately with respect to 
visual outcomes; however, refractive outcomes were analyzed as two groups: one month 
and up to one year post-operatively because the difference from the target refraction was 
evaluated rather than visual acuity. The difference between target refraction for distance 
eyes was compared to a “plano” target, while near vision eyes were aimed to specific age-
based refractive targets (between -0.75 and -2.50).  
 For distance-treated eyes analyzed collectively, the X2 tests indicated no difference 
between the two lasers at one month post-operatively when all treatment types were 
analyzed collectively (irrespective of LASIK or ASA). Specific treatment modalities were 
also analyzed individually. For LASIK-treated eyes one month post-operatively, both 
lasers produced comparable results in visual acuity. ASA-treated eyes were similarly 
comparable; however, due to the fewer number of eyes treated, trends in visual acuity 
outcomes were less apparent. Still, no statistically significant difference was calculated 
between the two lasers. 
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 Similarly, for distance eyes evaluated up to one year post-operatively, the two lasers 
produced similar trends near 20/20 uncorrected visual acuity. When comparing the two 
lasers without identifying any particular treatment type (LASIK or ASA), the two lasers 
produced significantly different results in visual acuity outcomes (p < 0.05). Eyes 
undergoing LASIK exhibited no statistical differences by one year post-operatively 
between either laser; ASA-treated eyes also showed statistically similar results on both 
lasers in the one year group. Unfortunately, the discrepancy in the overall group cannot 
only be attributed to laser performance. Moreover, regression in visual acuity following 
hyperopic LASIK treatments has been demonstrated in previous studies and may affect the 
results (Jaycock, O’Brart, Rajan, & Marshall, 2005). Additionally, the limited number of 
eyes measured on the Alcon laser (< 100 eyes) as compared to the VISX laser (>100 eyes) 
within one year post-operatively reduces the power of this particular measurement as 
compared to the one month group. With fewer eyes to evaluate on both lasers, the statistical 
significance of these interpretations must be analyzed further in more expansive studies to 
determine if this significance would increase or decrease with increased power. 
 Conversely, for eyes targeted toward reading vision, neither laser proved to be 
superior to the other. When viewed collectively, all treatment types achieved similar visual 
acuity outcomes as their distance counterparts. At one month post-operatively, irrespective 
of treatment type, both lasers produced visual acuities primarily of J1+, equivalent to 20/20 
distance vision. No differences could be statistically identified between either laser for 
LASIK and ASA groups separately by one month post-operatively. 
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 For the group assessed at up to one year post-operatively, no specific trend in visual 
outcomes could be identified for the monovision group due to the limited number of eyes 
treated on each laser. With these limited number of treatments, each laser still performed 
similarly according to measured outcomes. Neither the LASIK or ASA groups showed any 
statistically different outcomes individually. Much like the group of eyes treated for 
distance at one year, further studies would need to be conducted with a greater number of 
measured eyes to confirm the insignificance of these differences. 
Refractive outcomes were also assessed both at one month and up to one year post-
operatively. For all visual outcomes of 20/20 (distance) or J1+ (near), refractive targets 
were considered achieved. Not all patients whose one month or one year visual outcome 
was below 20/20 or J1+ (i.e. 20/20- or J1+-) were refracted possibly due to technician 
oversight or patient satisfaction. These visual acuities were not considered in final analysis. 
Of the refractions performed and the refractive targets achieved, both lasers produced 
nearly identical relative frequencies of refractive outcomes within 1 D by one month post-
operatively. Even in the up to one year post-operative group, both lasers produced 
comparable and statistically equivalent results with respect to refractive outcomes within 
1 D.  
The enhancement rate between the two lasers showed almost 8% on the VISX with 
only 4% on the Alcon laser; however, about half as many eyes were treated on the EX500 
than were treated on the VISX of eyes included in this study. When studying enhancement 
rate in the context of these two lasers, it is necessary to compare the rate of repeat surgery 
for hyperopic treatments in the context of established literature. Hyperopic LASIK has 
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been described with enhancement rates between 6% and 12.8% depending on the degree 
of hyperopia (Hersh, Fry, & Bishop, 2003; Randleman, White, Lynn, Hu, & Stulting, 
2009). This study departs from previous literature with respect to the Alcon EX500 excimer 
laser whose enhancement rate was calculated at approximately 4%; however, with only 
seven eyes included in the retreatment calculations, the interpretability of this number is 
greatly diminished. Moreover, this study does not specifically control for different levels 
of hyperopia which affected retreatment rate in other studies. Despite these potential 
confounding errors and the apparent difference in relative enhancement rates, no 
statistically significant difference between the two lasers could be identified. 
It follows these calculations and analyses that without any evidence of statistically 
significant differences in the majority of the aforementioned categories, this study expands 
on the conclusions of other similar studies conducted comparing other VISX and Alcon 
lasers. In previously established literature, both the VISX STAR S4 IR® and Alcon 
WaveLight® EX500 lasers served as safe and effective means of treatment for myopia and 
myopic astigmatism (J. Kanellopoulos & Asimellis, 2013; Meidani & Tzavara, 2016). 
Additionally, the CustomVue® option for the VISX STAR S4 IR® laser has been compared 
to the past generation of Alcon’s laser, the Allegretto WaveLight® Eye-Q excimer laser, 
with equal results for myopic patients (Moshirfar et al., 2011). In another study, one year 
post-operative outcomes between the two lasers for hyperopia also showed equivalent 
outcomes between the CustomVue® and Allegretto WaveFront Optimized treatments 
(Sáles & Manche, 2014). This study did not include any CustomVue® treatments for 
hyperopic eyes to best assess whether significantly altered visual outcomes appeared 
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between Wavefront-Optimized EX500 or traditional VISX treatments. A possible basis for 
any difference between the lasers could theoretically lie in higher order aberrations left 
untreated by traditional VISX and Wavefront-Optimized treatments; separate studies have 
been inconclusive regarding the HOA outcomes on these lasers (S. I. Kim et al., 2014; 
Moshirfar et al., 2011). Moreover, the unique focus on hyperopia using the EX500 
compared to the sixth generation VISX STAR S4 IR® provides new insight into the 
efficacy and safety of each laser. Neither laser produced significantly different outcomes 
consistently in any of the categories analyzed in this study.  
In future research on this topic, a few improvements presented here should be 
implemented. These include scheduling more consistent follow-ups, especially up to one 
year. In this study, the “up to one year” group included visual acuity and refractive 
measurements taken after one month and up to one year post-operatively, but that included 
measurements anywhere from 2 months to 12 months after the initial procedure. Ongoing 
post-operative complications or sub-optimal visual stabilizations during that period may 
have been included in statistical calculations, especially if the condition resolved itself to 
a point where the patient was satisfied with their vision but did not return for follow-up 
measurements within one year. It was also common for managing physicians to request 
that patients return for annual eye exams (after a year post-operatively) if their eyes were 
healthy and outcomes were acceptable within that 2 to 12-month period. In future studies, 
visual outcomes should be measured at 1-month, 6-months, and 12-months post-
operatively. 
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While provided post-operative instructions have been relatively standardized at the 
Boston Eye Group practices, an additional method of following up with patients to ensure 
compliance with post-operative instructions would help improve interpretability of the 
results as well. For example, not all patients undergoing ASA used the NSAID eye drops 
prescribed for pain, and no method of ensuring compliance with Vitamin C 
recommendations was consistently employed for these patients. Consistency in post-
operative examinations could be improved; namely, manifest refractions should be 
performed on all patients irrespective of visual acuity outcome to best determine 
quantifiable outcomes for each laser. Several patients were identified as having lost best 
corrected visual acuity (BCVA) after LVC; these eyes were included in calculations, but 
further analysis is required to determine if those losses occurred due to some cause 
independent of the treatment laser.  
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